Veterinary API Manufacturing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510243074

Publication Date:

October 28, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The increasing number of oral formulations for various veterinary drugs is boosting the demand for veterinary Active Pharmaceutical Ingredients (APIs). These majorly include nonsteroidal anti-inflammatory drugs. Manufacturers are investing in process synthesis, which helps in accelerating the manufacturing process for听active pharmaceutical ingredients.
The global market for Veterinary API Manufacturing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 142%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary API Manufacturing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Veterinary API Manufacturing by region & country, by Type, and by Application.
The Veterinary API Manufacturing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary API Manufacturing.
Market Segmentation
By Company
Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Menadiona
Afton Pharma
Jiangsu Lingyun Pharmaceutical Co., Ltd.
SUANFARMA
NGL Fine-Chem Ltd.
FIS - Fabbrica Italiana Sintetici S.p.A
Segment by Type:
Antiparasitic
Anti-infectives
NSAIDs
Vaccines
Biologics
Others
Segment by Application
In House
Contract Outsourcing
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Veterinary API Manufacturing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Veterinary API Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Veterinary API Manufacturing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Veterinary API Manufacturing Product Introduction
1.2 Global Veterinary API Manufacturing Market Size Forecast
1.3 Veterinary API Manufacturing Market Trends & Drivers
1.3.1 Veterinary API Manufacturing Industry Trends
1.3.2 Veterinary API Manufacturing Market Drivers & Opportunity
1.3.3 Veterinary API Manufacturing Market Challenges
1.3.4 Veterinary API Manufacturing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary API Manufacturing Players Revenue Ranking (2023)
2.2 Global Veterinary API Manufacturing Revenue by Company (2019-2024)
2.3 Key Companies Veterinary API Manufacturing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Veterinary API Manufacturing Product Offered
2.5 Key Companies Time to Begin Mass Production of Veterinary API Manufacturing
2.6 Veterinary API Manufacturing Market Competitive Analysis
2.6.1 Veterinary API Manufacturing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Veterinary API Manufacturing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary API Manufacturing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antiparasitic
3.1.2 Anti-infectives
3.1.3 NSAIDs
3.1.4 Vaccines
3.1.5 Biologics
3.1.6 Others
3.2 Global Veterinary API Manufacturing Sales Value by Type
3.2.1 Global Veterinary API Manufacturing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary API Manufacturing Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary API Manufacturing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 In House
4.1.2 Contract Outsourcing
4.2 Global Veterinary API Manufacturing Sales Value by Application
4.2.1 Global Veterinary API Manufacturing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary API Manufacturing Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary API Manufacturing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary API Manufacturing Sales Value by Region
5.1.1 Global Veterinary API Manufacturing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary API Manufacturing Sales Value by Region (2019-2024)
5.1.3 Global Veterinary API Manufacturing Sales Value by Region (2025-2030)
5.1.4 Global Veterinary API Manufacturing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Veterinary API Manufacturing Sales Value, 2019-2030
5.2.2 North America Veterinary API Manufacturing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Veterinary API Manufacturing Sales Value, 2019-2030
5.3.2 Europe Veterinary API Manufacturing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Veterinary API Manufacturing Sales Value, 2019-2030
5.4.2 Asia Pacific Veterinary API Manufacturing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Veterinary API Manufacturing Sales Value, 2019-2030
5.5.2 South America Veterinary API Manufacturing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Veterinary API Manufacturing Sales Value, 2019-2030
5.6.2 Middle East & Africa Veterinary API Manufacturing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary API Manufacturing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary API Manufacturing Sales Value
6.3 United States
6.3.1 United States Veterinary API Manufacturing Sales Value, 2019-2030
6.3.2 United States Veterinary API Manufacturing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary API Manufacturing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary API Manufacturing Sales Value, 2019-2030
6.4.2 Europe Veterinary API Manufacturing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary API Manufacturing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary API Manufacturing Sales Value, 2019-2030
6.5.2 China Veterinary API Manufacturing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary API Manufacturing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary API Manufacturing Sales Value, 2019-2030
6.6.2 Japan Veterinary API Manufacturing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary API Manufacturing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary API Manufacturing Sales Value, 2019-2030
6.7.2 South Korea Veterinary API Manufacturing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary API Manufacturing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary API Manufacturing Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary API Manufacturing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary API Manufacturing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary API Manufacturing Sales Value, 2019-2030
6.9.2 India Veterinary API Manufacturing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary API Manufacturing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alivira Animal Health Ltd.
7.1.1 Alivira Animal Health Ltd. Profile
7.1.2 Alivira Animal Health Ltd. Main Business
7.1.3 Alivira Animal Health Ltd. Veterinary API Manufacturing Products, Services and Solutions
7.1.4 Alivira Animal Health Ltd. Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.1.5 Alivira Animal Health Ltd. Recent Developments
7.2 Excel Industries Ltd.
7.2.1 Excel Industries Ltd. Profile
7.2.2 Excel Industries Ltd. Main Business
7.2.3 Excel Industries Ltd. Veterinary API Manufacturing Products, Services and Solutions
7.2.4 Excel Industries Ltd. Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.2.5 Excel Industries Ltd. Recent Developments
7.3 Ofichem Group
7.3.1 Ofichem Group Profile
7.3.2 Ofichem Group Main Business
7.3.3 Ofichem Group Veterinary API Manufacturing Products, Services and Solutions
7.3.4 Ofichem Group Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.3.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Developments
7.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
7.4.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Profile
7.4.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Main Business
7.4.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Products, Services and Solutions
7.4.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.4.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Developments
7.5 Menadiona
7.5.1 Menadiona Profile
7.5.2 Menadiona Main Business
7.5.3 Menadiona Veterinary API Manufacturing Products, Services and Solutions
7.5.4 Menadiona Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.5.5 Menadiona Recent Developments
7.6 Afton Pharma
7.6.1 Afton Pharma Profile
7.6.2 Afton Pharma Main Business
7.6.3 Afton Pharma Veterinary API Manufacturing Products, Services and Solutions
7.6.4 Afton Pharma Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.6.5 Afton Pharma Recent Developments
7.7 Jiangsu Lingyun Pharmaceutical Co., Ltd.
7.7.1 Jiangsu Lingyun Pharmaceutical Co., Ltd. Profile
7.7.2 Jiangsu Lingyun Pharmaceutical Co., Ltd. Main Business
7.7.3 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Products, Services and Solutions
7.7.4 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.7.5 Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Developments
7.8 SUANFARMA
7.8.1 SUANFARMA Profile
7.8.2 SUANFARMA Main Business
7.8.3 SUANFARMA Veterinary API Manufacturing Products, Services and Solutions
7.8.4 SUANFARMA Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.8.5 SUANFARMA Recent Developments
7.9 NGL Fine-Chem Ltd.
7.9.1 NGL Fine-Chem Ltd. Profile
7.9.2 NGL Fine-Chem Ltd. Main Business
7.9.3 NGL Fine-Chem Ltd. Veterinary API Manufacturing Products, Services and Solutions
7.9.4 NGL Fine-Chem Ltd. Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.9.5 NGL Fine-Chem Ltd. Recent Developments
7.10 FIS - Fabbrica Italiana Sintetici S.p.A
7.10.1 FIS - Fabbrica Italiana Sintetici S.p.A Profile
7.10.2 FIS - Fabbrica Italiana Sintetici S.p.A Main Business
7.10.3 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Products, Services and Solutions
7.10.4 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Revenue (US$ Million) & (2019-2024)
7.10.5 FIS - Fabbrica Italiana Sintetici S.p.A Recent Developments
8 Industry Chain Analysis
8.1 Veterinary API Manufacturing Industrial Chain
8.2 Veterinary API Manufacturing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary API Manufacturing Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary API Manufacturing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Menadiona
Afton Pharma
Jiangsu Lingyun Pharmaceutical Co., Ltd.
SUANFARMA
NGL Fine-Chem Ltd.
FIS - Fabbrica Italiana Sintetici S.p.A

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂